News

Two experts discuss why more research is needed before continuous glucose monitors can be used reliably for insulin ...
Glucotrack, which is developing a glucose monitor that is implanted through a minimally invasive surgery, said the small ...
GlucoModicum today announced positive outcomes from a clinical performance study of its needle-free continuous glucose ...
The CGM is based on magnetohydrodynamic (MHD) technology, which non-invasively samples interstitial fluid, the body fluid ...
In Q2 2025 Finland’s medicines agency, FIMEA, granted GlucoModicum authorization to initiate a new clinical investigation under Article 62 of the EU MDR (2017/745), enabling GlucoModicum to generate ...
GlucoTrack (GCTK) stock rocketed higher on Wednesday after the medical device company presented results from a clinical trial at the American Diabetes Association’s (ADA) 85th Scientific Sessions.
The study met all primary and secondary endpoints, demonstrating excellent accuracy with a Mean Absolute Relative Difference (MARD) of 7.7% across 122 matched pairs, a 99% data capture rate, and no ...
RUTHERFORD, N.J./STOCKHOLM - Glucotrack, Inc. (NASDAQ:GCTK), a micro-cap medical device company with a market capitalization of just under $3 million, announced Wednesday that its implantable ...
The study met all primary and secondary endpoints, demonstrating excellent accuracy with a Mean Absolute Relative Difference (MARD) of 7.7% across 122 matched pairs, a 99% data capture rate, and ...
RUTHERFORD, N.J./STOCKHOLM - Glucotrack, Inc. (NASDAQ:GCTK), a micro-cap medical device company with a market capitalization of just under $3 million, announced Wednesday that its implantable ...
The study met all primary and secondary endpoints, demonstrating excellent accuracy with a Mean Absolute Relative Difference (MARD) of 7.7% across 122 matched pairs, a 99% data capture rate, and ...
The mean relative absolute difference between CGM and other glucose measurements in the hospital was less than 14%. No correlation was observed with absolute relative difference and vital signs.